{"name":"Neuronascent, Inc.","slug":"neuronascent-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-08-13","type":"pipeline","source":"GlobeNewswire","summary":"Neuronascent Announces Progress for Lead Candidate NNI-362: - GlobeNewswire","headline":"Neuronascent Announces Progress for Lead Candidate NNI-362:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbmVOTThjWUFFZDhCNFU3TmM1V0VWOFhYdGVPXzNCN3hRWTJ1anY4d0dqTTNaVTBzY19pNl9VN1NYNFJhN3BKeUUtcUNZeGtXVjdYZUlKeFZWeHE2UTJfX0IwamwybGE2SklZY1lCd0o1elVyY2d4MXpLYUVvdVM2eTZ2ekRKS0pUZUJB?oc=5","date":"2022-06-01","type":"regulatory","source":"Yahoo Finance","summary":"Neuronascent Receives FDA Orphan Drug Designation for NNI-351 Treatment of Fragile X Syndrome - Yahoo Finance","headline":"Neuronascent Receives FDA Orphan Drug Designation for NNI-351 Treatment of Fragile X Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxQanhrZ3JEUEcxR180ZFozLWtMcVgyaFZpdVBBZHl2aUJ4alNTQjA3bGNXaUwzei1mM2dLSUYxOUNGbFVsbDluRFlGMUFIa0ZDWXF5MnZ3RG9YeUh3TjJycHJjR1JFd05hVmxzYXZROW15UWpkOUZ5MVZxaDU5OW1NRUkxdGc0MVJHdkYydThXWDdUM2YxS3pDRmtwenludTBXRUJ5MVlXX2tXTjlCd1Noa2ZsZmFZd2cxQTZKMnFDOFNZd0dxa3BLbWE1M1c3WE5ORmlKeGN2YnJXNThYYWRRSmRYZDhNVUw4RElpdG12c3BMWDlFOWx3QWxLUWQ2WVFub1FtN19zVVFacFJZc29ycF9RWjNDeGVfYkE?oc=5","date":"2022-04-26","type":"pipeline","source":"PR Newswire","summary":"Alzheimer's Disease Therapeutics Market 2022-2026 | Availability, Research, and Development of Novel Biomarkers to Boost Growth | Technavio - PR Newswire","headline":"Alzheimer's Disease Therapeutics Market 2022-2026 | Availability, Research, and Development of Novel Biomarkers to Boost","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}